Related Experiment Video
Updated: Jul 21, 2025

In Vitro Model of Coronary Angiogenesis
Published on: March 10, 2020
Role of Angiopoietic Coronary Endothelial Dysfunction in the Pathogenesis of Ischemic Cardiomyopathy
Svetlana P Chumakova1,2, Olga I Urazova1,2,3, Vladimir M Shipulin4
1Pathophysiology Division, Siberian State Medical University, Tomsk 634050, Russia.
Insights
Ischemic cardiomyopathy (ICMP) involves angiopoietic endothelial dysfunction, characterized by an imbalance of mediators and altered cell counts. This study explored these changes in patients with coronary heart disease (CHD).
Area of Science:
- Cardiovascular Research
- Endothelial Biology
- Molecular Medicine
Background:
- Endothelial dysfunction is a hallmark of ischemic cardiomyopathy (ICMP), but its angiopoietic aspects are poorly understood.
- Investigating endothelial progenitor cells (EPCs) and desquamated endothelial cells (EDCs) is crucial for understanding ICMP pathogenesis.
Purpose of the Study:
- To identify the imbalance of endothelial dysfunction mediators in patients with coronary heart disease (CHD).
- To quantify endothelial progenitor cells (EPCs) and desquamated endothelial cells (EDCs) in patients with and without ICMP.
Main Methods:
- Flow cytometry was used to determine EPCs (CD14+CD34+VEGFR2+) and EDCs (CD45-CD146+).
- ELISA and immunofluorescence assessed levels of HIF-1α, HIF-2α, ADMA, endothelin-1, angiopoietin-2, MMP-9, galectin-3, VEGF, PDGF, SDF-1, and MCP-1.
Main Results:
- ICMP patients showed HIF-1α deficiency and HIF-2α excess in vein blood.
- EDC levels increased in CHD patients, irrespective of ICMP.
- ICMP patients exhibited elevated galectin-3 in vein blood and increased EDCs, angiopoietin-2, MMP-9, and galectin-3 in sinus blood.
Conclusions:
- Ischemic cardiomyopathy (ICMP) is associated with angiopoietic endothelial dysfunction.
- The findings highlight specific molecular and cellular markers indicative of endothelial dysfunction in ICMP.
Background:
The angiopoietic endothelial dysfunction in ischemic cardiomyopathy (ICMP) remains unexplored.
Aim:
The identification of the imbalance of endothelial dysfunction mediators and the number of endothelial progenitor (EPC) and desquamated (EDC) cells in patients with coronary heart disease (CHD) with and without ICMP.
Methods:
A total of 87 patients (47 with ICMP and 40 without ICMP) were observed. The content of EPCs (CD14+CD34+VEGFR2+) in vein blood and EDCs (CD45-CD146+) in the blood from the coronary sinus and cubital vein was determined by flow cytometry. The contents of HIF-1α and HIF-2α in vein blood as well as that of ADMA and endothelin-1 in sinus plasma and angiopoietin-2, MMP-9 and galectin-3 in both samples were assessed using ELISA, and VEGF, PDGF, SDF-1 and MCP-1 contents using immunofluorescence.
Results:
ADMA and endothelin-1 levels in the sinus blood were comparable between the patient groups; a deficiency of HIF-1α and excess of HIF-2α were detected in the vein blood of ICMP patients. The EDC content in the vein blood increased in CHD patients regardless of ICMP, and the concentrations of VEGF-A, VEGF-B, PDGF, MCP-1, angiopoietin-2, and MMP-9 were normal. In ICMP patients, vein blood was characterized by an excess of galectin-3 and sinus blood by an excess of EDCs, angiopoietin-2, MMP-9 and galectin-3.
Conclusion:
ICMP is accompanied by angiopoietic endothelial dysfunction.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
08:22Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
Published on: April 15, 2020
Related Concept Videos
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease I: Introduction
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure